UNSPSC 51161531: Arofylline

This classification denotes a phosphodiesterase inhibitor with the molecular formula C14H13ClN4O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 87L38AY71R, chemically known as 3-(4-chlorophenyl)-1-propyl-3,7-dihydro-1h-purine-2,6-dione but generally known as arofylline, which bears US NIH Compound Identifier 166553. European Medicines Agency schedules Arofylline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05566MIG.

UNSPSC 51161531 Arofylline, a Commodity code, covers pharmaceutical active ingredients and finished-form medications supplied through state and local cooperative purchasing frameworks. State and local governments buy generic pharmaceuticals and over-the-counter products under this code, sourcing through multi-state cooperative agreements that aggregate demand across member agencies. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, is the primary issuing body visible in recent activity, establishing contracts with manufacturers to supply identified pharmaceutical products with specific National Drug Codes (NDCs) to state and local government facilities across participating jurisdictions. Vendors must comply with current Good Manufacturing Practices (cGMP), the Drug Supply Chain Security Act (DSCSA), and FDA requirements, maintain contractual relationships with authorized wholesalers (AmerisourceBergen Drug Corporation/Cencora, Cardinal Health 110 and 112, and Morris & Dickson Co., LLC), and carry comprehensive insurance including commercial general liability of $5,000,000 per occurrence and professional liability of $2,000,000. Pricing evaluation weights competitiveness at 75 percent, with secondary criteria addressing administrative compliance, EDI capability, and fixed-price adherence.

MMCAP's RFP (S1070000015802), issued January 20, 2026, with a response due date of March 26, 2026, is the sole recent opportunity visible in the source. The procurement spans Minnesota and Oregon as participating states, establishing two-year contract terms for new responders and extending through June 30, 2028 for existing incumbents. Award timing targets May 15, 2026, with contract effectiveness July 1, 2026. No specific set-aside designations or dollar values are disclosed in available solicitation materials; vendors should anticipate a 3 percent administrative fee on all purchases and performance penalties ranging from $200 to $1,500 per violation for reporting delays, onboarding failures, or improper class-of-trade denials.